BioHorizons, Inc., a majority-owned subsidiary of Henry Schein, Inc. (NASDAQ:HSIC), is a leading dental implant and biologics company located in Birmingham, Alabama. The company has a broad product offering, including dental implants, surgical planning software and tissue regeneration solutions for the replacement of missing teeth. BioHorizons products are available in 85 markets around the world. For more information, visit biohorizons.com.
|
|
|
201-500 employees
View all BioHorizons employees
|
|
Medical Devices
|
|
2300 Riverchase Center, Birmingham, Alabama 35244, US
|
|
1994
|
|
Dental Implants, Dental Instruments, Biologics, Dental Implant Prosthetics, Laser-Lok Microchannels, Treatment Planning Software, Dental Implant Education
|
Steve Boggan is the CEO of BioHorizons. To contact Steve Boggan email at [email protected].
The decision makers in BioHorizons are Boyd Peters, David Langie, Dean Dehling, etc. Click to Find BioHorizons decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.